JEFFREY DOWNING: Open Payments
NPI 1538569553 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 60 payments from 15 companies in 2025. Trend: 2023 $1,738 · 2024 $1,328 · 2025 $1,191
Food & beverage: $1,186Education: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 22 | $289 |
| TOLMAR, INC. | 9 | $158 |
| Teleflex LLC | 1 | $149 |
| ABBVIE INC. | 2 | $129 |
| IMMUNITYBIO, INC. | 5 | $83 |
| Janssen Biotech, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Antares Pharma, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $36 |
Products named: GEMTESA, BARRIGEL, AVYCAZ, ORGOVYX, ELIGARD, ANKTIVA, PLUVICTO, JATENZO.
Industry payments across NJ — which companies pay providers there.
